Press Release
Best in Class: Scottsdale Wound Management Guide
Comprehensive pocket handbook offers differential diagnosis and treatment options at your fingertips
Malvern, PA (June 8, 2009) – Proper wound care management has become one of the top concerns for many clinicians across various medical specialties. Treatment is specific to the wound type, the patient and the long-term care plan and requires ongoing assessment. Read More
2009 WOUNDS Article Index
Education
ON-DEMAND WEBCAST - How Advanced Wound Dressing Technology Helps Progress Chronic Wound Healing
Non-Accredited
Taking the Complexity Out of Diabetic Foot Management - Complimentary On-Demand Webcast
Non-Accredited
Simple Steps in Wound Healing to Achieve Success for Your Patients and Practice - Complimentary On-Demand Webcast
Non-Accredited
CLINICAL EVENTS CALENDAR
- Wound Clinic Business MeetingStart Date:June 18, 2010End Date:June 18, 2010
Crowne Plaza, Chicago O'Hare
- SAWC FallStart Date:September 23, 2010End Date:September 25, 2010
Anaheim Convention Center
Issue
- Issue:3
Anacapa Technologies, Inc. – Booth 723
Anasept™ Skin & Wound Antiseptic is a non-cytotoxic, extremely fast-acting, antimicrobial skin and wound cleanser with broad-spectrum, bactericidal (including the antibiotic resistant strains MRSA & VRE, and Acinetobacter baumanii) , fungicidal and virucidal properties. Anasept is available in both spray and pour bottle applicators.
- Issue:3
The development of an infected acute wound porcine model
D. Boone, MD, E. Braitman, MD, J. Afthinos, MD, C. Gendics, RN, E. Sordillo, MD, PhD, G. Todd, MD, J. Lantis, MD - Issue:3
Disclosure: Dr. Granick was a medical consultant for Smith & Nephew Inc (Largo, Fla)
- Issue:3
With longer survival rates of patients with diabetes the incidence of Charcot arthropathy has been noted to be increasing in occurrence within the last several years.1 Charcot arthropathy is a noninfective progressive process that was first reported by Jean-Martin Charcot in 1868.2 It was originally described in neuropathic patients with tertiary syphilis, although it is now most commonly associated with diabetes mellitus.
- Issue:3
Diabetes and Lesions of the Foot
Diabetes is a common condition in the United States, affecting more than 10 million adults.1 Wounds of the foot are the most common reason for hospitalization in patients with diabetes;2,3 it is estimated that 15% to 20% of patients with diabetes will develop an ulcer on their foot at some point,4 and for many of these cases, the most appropriate treatment results in some form of surgery.
- Issue:3
NPWT Therapy More Effective Than Alternate Treatment
Kinetic Concepts Inc (San Antonio, Tex) announced the final results of a randomized controlled clinical trial for the efficacy of the company’s V.A.C.® System negative pressure wound therapy compared to advanced moist wound therapy (AMWT) in treating diabetic foot ulcers.
- Issue:3
New Educational Campaign Launched for Apligraf®
Organogenesis Inc (Canton, Mass) is launching a direct-to-consumer educational campaign for its living cell-based therapy, Apligraf®.
Designed to treat venous leg ulcers and diabetic foot ulcers, Apligraf contains 2 layers of living cells that integrate into the wound and produce more than 40 substances, such as cytokines, that are important to healing.
WOUNDS Monthly Poll
Anytown, California
WOUNDS News Wire
- Tuesday, July 27, 2010 - 14:47
- Tuesday, July 27, 2010 - 14:45
- Wednesday, July 21, 2010 - 12:17
REVIEW OUR OTHER
WOUND CARE BRANDS
Check out our other resources for healthcare professionals of all specialties.
